Sotaro Enatsu

1.6k citations
41 papers · 721 indexed · h-index 14
Topics
Lung Cancer Treatments and Mutations (31 papers)Colorectal Cancer Treatments and Studies (19 papers)Lung Cancer Research Studies (9 papers)

In The Last Decade

Sotaro Enatsu

38 papers receiving 707 citations

Peers

Sotaro Enatsu
Comparison fields: 5 of 69
  • Oncology 405
  • Pulmonary and Respiratory Medicine 399
  • Molecular Biology 306
  • Cancer Research 97
  • Cell Biology 47
Replace A. Delacruz with:
A. Delacruz United States
Steve Bender United States
Evangelos Bournakis Greece
Raymond Wadlow United States
Weiguo Qing United States
Shinichiro Ryuge Japan
Leslie Smetzer United States
Nicoletta Cordani Italy
Mark S. Albom United States
Hiroaki Ozasa Japan
Sotaro Enatsu relative to A. Delacruz United States A. Delacruz's profile →
Citations per field
00.5×
A. Delacruz · 1×
Citations per year

Countries citing papers authored by Sotaro Enatsu

Since Specialization
Citations

This map shows the geographic impact of Sotaro Enatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sotaro Enatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sotaro Enatsu more than expected).

Fields of papers citing papers by Sotaro Enatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sotaro Enatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sotaro Enatsu. The network helps show where Sotaro Enatsu may publish in the future.

Co-authorship network of co-authors of Sotaro Enatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Sotaro Enatsu. A scholar is included among the top collaborators of Sotaro Enatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sotaro Enatsu. Sotaro Enatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 5
4 2
5 16
6 31
7 14
8 7
9 0
10 7
11 1
12 1
13 1
14 5
15 74
16 9
17 2
18 8
19 23
20 52

About Sotaro Enatsu

Sotaro Enatsu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 41 papers that have together received 721 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), Colorectal Cancer Treatments and Studies (19 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Oncology (405 citations), Pulmonary and Respiratory Medicine (399 citations) and Cancer Research (97 citations). Sotaro Enatsu has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kazuhiko Nakagawa, James Chih‐Hsin Yang, Mauro Orlando, Jianxing He, Tarun Puri, Joo-Hang Kim, Haruyasu Murakami, Pan‐Chyr Yang, Jin Hyoung Kang and Ying Cheng. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026